Figure 2.

The time course of the abdominal computed tomography findings suggest that peritoneal dissemination was progressing slowly. (a) In May 2012, high‐density lesions in the intestine were not observed before chemotherapy. (b) In November 2013, the patient was receiving bevacizumab, and 2 months before the onset of appendicitis, high‐density lesions in the intestine (inside the yellow line) and small ascites (not shown) were observed. (c) In August 2014, 7 months after the onset of appendicitis, high‐density lesions in the intestine (inside the yellow line) and the ascites (yellow indicator) were increased.